Nexalin Technology (NXL) Current Leases (2021 - 2023)

Nexalin Technology's (NXL) quarterly Current Leases came in at $4463.0 in Q4 2023, down 91.21% year-on-year from $50797.0 in Q4 2022, and down 74.69% quarter-over-quarter from $17635.0 in Q3 2023.

Nexalin Technology (NXL) Current Leases (2021 - 2023) Analysis & Trends

Nexalin Technology's Current Leases history runs 3 years deep, the most recent figure standing at $4463.0 for Q4 2023.

  • On a quarterly basis, Current Leases fell 91.21% year-over-year to $4463.0 in Q4 2023; TTM through Dec 2023 was $4463.0, a 91.21% decrease from a year earlier, with the FY2023 full-year figure at $4463.0, down 91.21% from the prior year.
  • Current Leases slipped to $4463.0 in Q4 2023 per NXL's latest filing, from $17635.0 in the prior quarter.
  • Across five years, Current Leases topped out at $50797.0 in Q4 2022 and bottomed at $4463.0 in Q4 2023.
  • The 3-year median for Current Leases is $40845.0 (2021), against an average of $33830.7.
  • Across the five-year window, Current Leases increased 24.37% in 2022 and slumped 91.21% in 2023, its largest moves.
  • Year by year, Current Leases stood at $40845.0 in 2021, then gained by 24.37% to $50797.0 in 2022, then slumped by 91.21% to $4463.0 in 2023.
  • Per Business Quant, the three latest NXL Current Leases figures stand at $4463.0 (Q4 2023), $17635.0 (Q3 2023), and $30487.0 (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Nexalin Technology 9.32 Mn 6.61 Mn 13,133.00 -

Historic Data

Download Data
DateValue
Dec 31, 2023 4,463.00
Sep 30, 2023 17,635.00
Jun 30, 2023 30,487.00
Mar 31, 2023 43,026.00
Dec 31, 2022 50,797.00
Sep 30, 2022 49,562.00
Dec 31, 2021 40,845.00